OMNILINK ELITE PERIPHERAL STENT SYSTEM
Report
- Report Number
- 2024168-2012-07578
- Event Type
- Injury
- Date Received
- November 30, 2012
- Date of Event
- November 7, 2012
- Report Date
- November 7, 2012
- Manufacturer
- AV-TEMECULA-CT
- Product Code
- NIO
- PMA / PMN Number
- P110043
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- TN, US
- Reporter Occupation
- HEALTH PROFESSIONAL
Narratives
(B)(4). DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE EVENT, PATIENT AND DEVICE INFORMATION. (B)(4). THE DEVICE WAS RECEIVED. INVESTIGATION IS NOT YET COMPLETE. A FOLLOW-UP REPORT WILL BE SUBMITTED WITH ALL ADDITIONAL RELEVANT INFORMATION.
(B)(4). EVALUATION SUMMARY: THE DEVICE WAS RETURNED FOR ANALYSIS. THE STENT DISLODGEMENT WAS ABLE TO BE CONFIRMED; HOWEVER, THE INFLATION DIFFICULTIES WERE UNABLE TO BE CONFIRMED. BASED ON A VISUAL AND FUNCTIONAL INSPECTION OF THE RETURNED DEVICE, THERE IS NO INDICATION OF A PRODUCT DEFICIENCY. A REVIEW OF THE LOT HISTORY RECORD REVEALED NO NON-CONFORMANCES THAT WOULD HAVE CONTRIBUTED TO THE REPORTED EVENT. THE RESULTS OF THE QUERY OF SIMILAR INCIDENTS IN THE COMPLAINT HANDLING DATABASE FOR THIS LOT DID NOT INDICATE A MANUFACTURING ISSUE. IT SHOULD BE NOTED THE OMNILINK ELITE VASCULAR BALLOON EXPANDABLE STENT SYSTEM INSTRUCTIONS FOR USE STATES: THE OMNILINK ELITE STENT SYSTEM IS INDICATED FOR THE TREATMENT OF ATHEROSCLEROTIC ILIAC ARTERY LESIONS. BASED ON THE REVIEWED INFORMATION, NO PRODUCT DEFICIENCY WAS IDENTIFIED.
IT WAS REPORTED THAT DURING THE PROCEDURE TO TREAT A LESION IN THE SUBCLAVIAN ARTERY, PRE-DILATATION WAS PERFORMED USING AN UNSPECIFIED 8 MM DILATATION CATHETER. THE OMNILINK ELITE STENT DELIVERY SYSTEM WAS ADVANCED INTO THE PATIENT ANATOMY AND TO THE TARGET LESION. THE STENT DELIVERY SYSTEM BALLOON WAS INFLATED; HOWEVER, ONLY THE DISTAL END OF THE BALLOON INFLATED AND THE STENT WAS PUSHED PROXIMALLY, ONTO THE SHAFT OF THE STENT DELIVERY SYSTEM. AN ATTEMPT WAS MADE TO REMOVE THE DEVICE, BUT THE STENT CAME OFF THE STENT DELIVERY SYSTEM AND DISLODGED IN THE SUBCLAVIAN ARTERY AND EXTENDED INTO THE AORTA. THE STENT DELIVERY SYSTEM WAS USED TO EXPAND THE STENT. ADDITIONAL DILATATION WAS PERFORMED USING A 10 X 30 X 135 MM NON-ABBOTT DILATATION CATHETER AND A 12 X 20 X 135 MM NON-ABBOTT DILATATION CATHETER TO FULLY APPOSE THE STENT TO THE VESSEL WALL AND FLARE THE PORTION OF THE STENT REMAINING IN THE AORTA. A NON-ABBOTT STENT WAS THEN IMPLANTED TO TREAT THE STENOSIS IN THE SUBCLAVIAN ARTERY. THERE WERE NO ADVERSE PATIENT SEQUELA; HOWEVER, THERE WAS A CLINICALLY SIGNIFICANT DELAY REPORTED. NO ADDITIONAL INFORMATION WAS PROVIDED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | OMNILINK ELITE PERIPHERAL STENT SYSTEM | PERIPHERAL STENT SYSTEM | NIO | AV-TEMECULA-CT | 2062041 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 60 YR | Required Intervention |